Národný Onkologický Ústav

Erdheim-Chester disease diagnosed and treated at the Hematology and Oncology Clinic of the Brno University Hospital in the last 26 years. Description of 6 cases and an overview of the symptoms and treatment of this disease

Zdeněk Adam, Zdeněk Řehák, Karel Starý, Richard Chaloupka et autres

Erdheimova-Chesterova choroba (ECD) je malign histiocytrn nemoc, kter je obvykle provzen systmovou zntlivou reakc, kter me bt zhodnocena jako horeka nejasnho pvodu (fever of unknown origin). Charakteristick jsou osteosklerotick kostn zmny. Typickm znakem je zven akumulace osteotropnch radiofarmak v okol kolennch kloub …

cz, sk (code pays fourni par la source)

Cara buka Blokir bws mobile salah password 3 kali

Katarina Ondrejkova

Untuk buka blokir (BWS) Mobile Anda dapat menghubungi call center (BWS) mobile melalui via chat WhatsApp di (+62821.4444.012), atau 15OO-O12. atau langsung datang ke kantor cabang terdekat atau coba opsi reset password di aplikasi BWS Mobile melalui halaman login.

sk (code pays fourni par la source)

Cara buka Blokir bws mobile salah password 3 kali

Katarina Ondrejkova

Untuk buka blokir (BWS) Mobile Anda dapat menghubungi call center (BWS) mobile melalui via chat WhatsApp di (+62821.4444.012), atau 15OO-O12. atau langsung datang ke kantor cabang terdekat atau coba opsi reset password di aplikasi BWS Mobile melalui halaman login.

sk (code pays fourni par la source)

História klinickej biochémie v Národnom ústave detských chorôb / History of clinical biochemistry at the National Institute of Children's Diseases

A. Vasilenkova, Claudia Šebová

sk (code pays fourni par la source)

História klinickej biochémie v Národnom ústave detských chorôb / History of clinical biochemistry at the National Institute of Children's Diseases

A. Vasilenkova, Claudia Šebová

sk (code pays fourni par la source)

A global multicenter, open-label, randomized, phase 3 registrational study of lisaftoclax (APG-2575) in previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): GLORA trial in progress.

Matthew S. Davids, Sikander Ailawadhi, Gerardo Musuraca, Wojciech Jurczak et autres

TPS7101 Background: Patients with high-risk CLL/SLL not achieving a complete response (CR) after ≥ 12 months of BTK inhibitor (BTKi) monotherapy remain at risk for early progression due to residual disease and BTKi resistance. A BCL-2 inhibitor (BCL-2i) introduces a complementary, BCR-independent …

us, it, pl, cz, es, ru, fr, ro, sk (code pays fourni par la source)

27P Chemotherapy (chemo) rechallenge in patients (pts) with EGFR-mutated (EGFRm) advanced NSCLC who discontinued 1L osimertinib (osi) + platinum–pemetrexed (plat–pem) due to progression (PD): FLAURA2 exploratory analysis

C. Escriu, P.A. Jänne, D. Planchard, J.C-H. Yang et autres

In the phase III, global, open-label FLAURA2 study (NCT04035486), 1L osi + plat–pem significantly improved PFS and OS vs osi monotherapy (mono) in pts with EGFRm advanced NSCLC. In the osi + plat–pem arm, the median duration of exposure to osi was …

gb, us, fr, tw, pe, ru, jp, kr, cn, th, vn, sk, br, sg, es (code pays fourni par la source)

Sexual health of patients after oncological treatment - how to improve quality of life, the impact of oncological treatment on sexual health and reproductive ability of men, rehabilitation options and psychological support

Taťána Šrámková

Onkologick lba a samotn onemocnn mohou vznamn ovlivnit sexualitu pacient, a to jak v oblasti fyziologickch funkc, tak v psychick a vztahov rovin. Mezi nejastj problmy pat sexuln dysfunkce, zmny v sebepojet a partnersk dynamice. Pestoe sexualita zstv dleitou soust kvality ivota …

sk, cz (code pays fourni par la source)

Actual possibilities of target therapy for Non-Small Cell Lung Cancer in Czech Republic

Monika Bratová

Clen lba nemalobunnho karcinomu plic (NSCLC) zaznamenala v poslednch letech dal vznamn posun. Do praxe byly uvedeny nov clen preparty (RET, KRAS, MET, ROS1, BRAF inhibitory, HER2 blokda). Dle se rozila indikace terov terapie do adjuvantnho uit (osimertinib, alectinib) i do kombinace …

cz, sk (code pays fourni par la source)

Immunotherapy in the treatment of metastatic non-small cell lung cancer

Ondřej Bílek

Imunoterapie zaloen na inhibici kontrolnch bod imunity (checkpoint inhibitory) se stala nedlnou soust standardnch lebnch algoritm nemalobunnho karcinomu plic (NSCLC) nap lebnmi liniemi. Inhibitory PD-1 a PD-L1 jsou indikovny v monoterapii, jako kombinovan imunoterapie s inhibitory CTLA-4 nebo v kombinaci s jinmi …

sk (code pays fourni par la source)

The role of art-making as a part of treatment in women with breast cancer

Erika Zbiňovská, Hana Hobzová

BACKGROUND: Comprehensive treatment of patients with cancer includes various forms of psychosocial support aimed at improving the quality of life of patients. Psychosocial interventions help manage psychological distress and physiological symptoms associated with cancer and its treatment. These interventions include art therapy, …

sk, gb (code pays fourni par la source)

Atypical rash

Edita Marvanová, Hana Jedličková, Lukáš Velecký, Katarína Petráková

Metastzy solidnch ndor do ke jsou vzcn, jejich klinick obraz je heterogenn a mohou napodobovat jin kon projevy. Vodtkem ke sprvn diagnze je dkladn anamnza, klinick a histologick vyeten. Kazuistika popisuje ppad pacientky s konmi metastzami karcinomu prsu.

cz, sk (code pays fourni par la source)